AstraZeneca admits Covid vaccine could cause potentially fatal side effect — RT World News

Pharmaceutical giant AstraZeneca has admitted for the first time that its coronavirus vaccine could cause rare side effects that could lead to blood clots and death, according to court documents.

The company is facing a class-action lawsuit alleging that its vaccine, developed in collaboration with the University of Oxford, could lead to death and serious injury.

The legal battle was started by Jamie Scott, a father of two, who suffered a blood clot that left him with brain damage after receiving the vaccination in April 2021 amid the Covid-19 pandemic. He is seeking compensation over allegations that the AstraZeneca vaccine is “defective” And less secure than expected, a claim the company denies.

In May 2023, AstraZeneca also insisted on this “We do not accept this text-to-speech [Thrombosis with Thrombocytopenia Syndrome] “It is caused by the vaccine at the general level.” As reported by the Daily Telegraph.

TTS is a rare condition, in which a person develops blood clots, which may reduce blood flow, as well as a low platelet count, which can lead to difficulties stopping bleeding. Symptoms of TTS include severe headaches and abdominal pain.

Despite previous denials, AstraZeneca said in court documents, which were submitted to the UK Supreme Court in February but have only recently received media attention, that “It is recognized that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is unknown.”

“Furthermore, TTS can also occur in the absence of the AZ vaccine (or any vaccine).” The company added, according to what was reported by The Telegraph newspaper.

Meanwhile, AstraZeneca insists that available data shows that the drug actually worked “Acceptable security profile” And that “Regulators around the world consistently state that the benefits of vaccination outweigh the risks of very rare potential side effects.”

Dozens of Western countries suspended the use of the AstraZeneca vaccine in the spring of 2021 due to concerns that it might cause some patients to develop blood clots. At the time, the head of the European Medicines Agency's (EMA) vaccine strategy, Marco Cavalieri, said there was a clear link between taking the AZ vaccine and blood clots in the brain, but stressed that the benefits still outweighed the risks.

According to World Health Organization data, the effectiveness of the AstraZeneca coronavirus vaccine is 72%. As of April 2021, more than 17 million people have received the vaccine in the European Union and the United Kingdom, with just under 40 cases of blood clots, according to the company.